ClinicalTrials.govpublic full text
Effect of Dapagliflozin on Insulin Secretion and Insulin Sensitivity in Patients With Prediabetes
prediabetes, impaired fasting glucose, impaired glucose tolerance, hyperglycemia, glucose intolerance, dapagliflozin, sodium glucose cotransporter 2 inhibitor, sglt2, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 858070
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.